Excision Medical is developing a Leaflet Excision System that enables targeted removal of aortic valve leaflets to mitigate risks associated with redo transcatheter aortic valve replacement (TAVR) procedures. This technology addresses the limitations of current leaflet modification methods, enhancing patient safety and improving procedural outcomes for those with bioprosthetic valve failure.
Funding
$18.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Redo transcatheter aortic valve replacement (TAVR) procedures are often complicated by the presence of the existing failed valve, which can lead to acute obstruction of the coronary artery ostia and other hazards. Current methods for modifying leaflets before redo TAVR are limited and can be time-consuming. There are currently no commercially available methods for meaningful leaflet modification involving complete leaflet excision.
Solution
Excision Medical is developing a Leaflet Excision System designed to enable targeted removal of aortic valve leaflets, mitigating risks associated with redo TAVR procedures. The system allows physicians to target and excise one or more aortic valve leaflets while considering the hemodynamic needs of patients. Leaflet removal is key to mitigating the risk of coronary artery ostia obstruction and debulking the existing valve prior to the redo TAVR, which may also offer additional benefits to the performance of the new valve. The system is designed to integrate into the workflow of TAVR procedures.
Target Audience
The primary users are physicians specializing in structural heart disease, specifically those performing TAVR and redo TAVR procedures.
Features
- Stýri™ Steering Catheters for precise navigation and positioning.
- Viking™ RF Excision Catheter for targeted leaflet removal.
- HemoShield™ Temporary Valve to maintain hemodynamic stability during the procedure.
- Patent-pending leaflet modification technology.